Alfons Meindl

发表

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository

Rosemary L. Balleine, Christine L. Clarke, D. Gareth Evans, 2014 .

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

Jane E. Carpenter, Kyriaki Michailidou, France Labrèche, 2014, Human molecular genetics.

Footwear with tweaking weft seal and process for its manufacture

Alfons Meindl, Xaver Haimerl, 1999 .

Footwear with sealed sole construction and process for its manufacture

Alfons Meindl, Xaver Haimerl, 1999 .

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer

Dieter Niederacher, Alfons Meindl, Norbert Arnold, 2020, Geburtshilfe und Frauenheilkunde.

A sealed shoe and process for its manufacture

Alfons Meindl, Xaver Haimerl, 1999 .

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer.

Alfons Meindl, Barbara Burwinkel, Sandrine Tchatchou, 2006, Carcinogenesis.

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

Alfons Meindl, Marc Ladanyi, Takafumi Ueda, 2001, Oncogene.

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer

Tanja Fehm, Nina Ditsch, Dieter Niederacher, 2016, Journal of Medical Genetics.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

Matthias W. Beckmann, Peter A. Fasching, Simon S. Cross, 2016, American journal of human genetics.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure

Chris Sander, Thomas Meitinger, Peer Bork, 1993, Nature Genetics.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Daniel J. Park, Julian Peto, Kamila Czene, 2012, Cancer research.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.

Dieter Niederacher, Alfons Meindl, Barbara Burwinkel, 2005, Carcinogenesis.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Gary D. Bader, Christine L. Clarke, Gary D Bader, 2020, Nature Communications.

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

Susanne Seitz, Dieter Niederacher, Alfons Meindl, 2009, International journal of cancer.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

Jianxin Shi, Daniel F. Schmidt, Nazneen Rahman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

Mads Thomassen, Julian Peto, Peter A. Fasching, 2013, PLoS genetics.

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Dieter Niederacher, Alfons Meindl, Bertram Müller-Myhsok, 2010, Nature Genetics.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Patrick Neven, Hui Zhao, Nazneen Rahman, 2012, PloS one.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

Nina Ditsch, Steffi Oesterreich, Dieter Niederacher, 2009, BMC Cancer.

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

Peter Kraft, Mads Thomassen, Daniel J. Park, 2013, Breast Cancer Research.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL‐ and cisplatin‐induced apoptosis in human ovarian cancer cells

Alfons Meindl, Tibor Schuster, Marion Kiechle, 2013, International journal of cancer.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Gene-panel sequencing and the prediction of breast-cancer risk.

Nazneen Rahman, Peter Devilee, Alfons Meindl, 2015, The New England journal of medicine.

Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

Nina Ditsch, Peter Nürnberg, Dieter Niederacher, 2018, Cancer medicine.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.

Steven Gallinger, Peter Kraft, Nazneen Rahman, 2016, Cancer research.

Breast cancer susceptibility: current knowledge and implications for genetic counselling

Alfons Meindl, Brigitte Schlegelberger, A. Meindl, 2009, European Journal of Human Genetics.

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

Wei Lu, Päivi Heikkilä, Peter Kraft, 2013, American journal of human genetics.

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

Patrick Neven, Michael Jones, Wei Lu, 2013, Nature Genetics.

Five endometrial cancer risk loci identified through genome-wide association analysis

Hui Zhao, Mark McEvoy, Julian Peto, 2016, Nature Genetics.

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

Nina Ditsch, Michael Golatta, Alfons Meindl, 2012, Breast Cancer Research.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Patrick Neven, Chiun-Sheng Huang, Julian Peto, 2014, Breast Cancer Research.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

Identification of Novel Susceptibility Genes for Breast Cancer – Genome-Wide Association Studies or Evaluation of Candidate Genes?

Alfons Meindl, A. Meindl, 2009, Breast Care.

Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.

Nina Ditsch, Alfons Meindl, Rita K Schmutzler, 2011, Deutsches Arzteblatt international.

MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early‐onset cases

Dieter Niederacher, Alfons Meindl, Heide Hellebrand, 2008, Human mutation.

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study

Alfons Meindl, Barbara Burwinkel, Marion Kiechle, 2006, BMC Cancer.

BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study

Alfons Meindl, Barbara Burwinkel, Peter Bugert, 2007, BMC Cancer.

Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly.

Matthias Platzer, Alfons Meindl, R. Stevenson, 2004, American journal of human genetics.

Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction

Alfons Meindl, Rita K. Schmutzler, Eric Hahnen, 2012, PloS one.

11q13 is a susceptibility locus for hormone receptor positive breast cancer

Patrick Neven, Michael Jones, Michael Bremer, 2012, Human mutation.

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Michael Jones, Julian Peto, Thomas Brüning, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Wei Lu, Nina Ditsch, Julian Peto, 2013, American journal of human genetics.

Identification of nine new susceptibility loci for endometrial cancer

Peter Kraft, Mark McEvoy, Julian Peto, 2018, Nature Communications.

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Michael Golatta, Walter Heindel, Barbara Krug, 2019, Breast Cancer Research and Treatment.

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Michael Jones, Nazneen Rahman, Daniel J. Park, 2012, Nature Genetics.

Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.

Alfons Meindl, Barbara Burwinkel, Peter Bugert, 2007, Carcinogenesis.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.